Search Within

Gopakumar Vasudeva Iyer

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (118)
  2. Journal Article (70)
  3. Correspondence (2)
  4. Editorial (2)
  5. Book Section (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (194)
  2. GSK Faculty (194)
  3. Genitourinary Oncology Service (194)
  4. Solid Tumor Oncology Division (194)
  5. Human Oncology and Pathogenesis Program (186)
  6. Department of Pathology and Laboratory Medicine (177)

More Groups

People
  1. David Solit (181)
  2. Hikmat Al-Ahmadie (152)
  3. Dean Bajorin (121)
  4. Jonathan Rosenberg (112)
  5. Bernard Bochner (110)
  6. Michael Berger (102)

More People

Years
  1. 2025 (4)
  2. 2024 (13)
  3. 2023 (10)
  4. 2022 (16)
  5. 2021 (18)
  6. 2020 (14)

More Years

Publications
  1. Journal of Clinical Oncology (54)
  2. Laboratory Investigation (27)
  3. Modern Pathology (20)
  4. Cancer Research (14)
  5. Clinical Cancer Research (12)
  6. European Urology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (61)
  2. Nature Publishing Group (39)
  3. American Association for Cancer Research (29)
  4. Nature Research (20)
  5. Elsevier Inc. (12)
  6. Elsevier Science, Inc. (9)

More Publishers

Results (194)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lessons from the study of exceptional responders
    Editorial

    Elzein, A.; Iyer, G.; Solit, D. B.
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • MSK-ACCESS for the detection of fibroblast growth factor receptor-3 (FGFR3) mutations in plasma cell-free (cf)DNA of metastatic urothelial carcinoma (mUC) patients (pts) pre- and on erdafitinib (erda) therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Al-Ahmadie, H.; Brannon, A. R.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Fibroblast growth factor receptor 3 alteration status is associated with differential sensitivity to platinum-based chemotherapy in locally advanced and metastatic urothelial carcinoma
    Journal Article

    Teo, M. Y.; Mota, J. M.; Whiting, K. A.; Li, H. A.; Funt, S. A.; Lee, C. H.; Solit, D. B.; Al-Ahmadie, H.; Milowsky, M. I.; Balar, A. V.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Germ cell tumor molecular heterogeneity revealed through analysis of primary and metastasis pairs
    Journal Article

    Cheng, M. L.; Donoghue, M. T. A.; Audenet, F.; Wong, N. C.; Pietzak, E. J.; Bielski, C. M.; Isharwal, S.; Iyer, G.; Funt, S.; Bagrodia, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of extreme responses to anti-PD1/PDL1 checkpoint inhibitors (CPI) in metastatic urothelial cancer (mUC)
    Meeting Abstract

    Teo, M. Y.; Whiting, K.; Mota, J. M.; Li, H.; Regazzi, A. M.; Solit, D. B.; Aggen, D. H.; Lee, C. H.; Funt, S. A.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Final results from the phase I study expansion cohort of the selective FGFR inhibitor Debio 1,347 in patients with solid tumors harboring an FGFR gene fusion
    Meeting Abstract

    Cleary, J. M.; Iyer, G.; Oh, D. Y.; Mellinghoff, I. K.; Goyal, L.; Ng, M. C. H.; Meric-Bernstam, F.; Matos, I.; Chao, T. Y.; Sarkouh, R. A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma
    Journal Article

    McPherson, V.; Reardon, B.; Bhayankara, A.; Scott, S. N.; Boyd, M. E.; Whiting, K.; Garcia-Grossman, I. R.; Regazzi, A. M.; McCoy, A. S.; Kim, P. H.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer
    Meeting Abstract

    Walasek, A.; Almassi, N.; McPherson, V.; Dason, S.; Benfante, N.; Klein, T.; Berger, M. F.; Schultz, N.; Dalbagni, G.; Bajorin, D. F.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma
    Meeting Abstract

    Walasek, A.; Almassi, N.; Teo, M. Y.; Funt, S.; Schultz, N.; Dalbagni, G.; Hu, W.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save